N3-Substituted thymidine analogues: Radiosyntheses of N3-[4-(4-(2-[18F] fluoroethyl)phenyl)butyl]thymidine and N3-[5-(4-(2-[18F]fluoroethyl)phenyl)pentyl]thymidine for PET

Current Radiopharmaceuticals

Volumn 2, Issue 1, 2009, Pages 2-8

  Ghosh, Pradip ^a   Gelovani, Juri G ^a   Alauddin, Mian M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fluorine 18; N3 substitued thymidine; PET; TK1

Indexed keywords

N 3 [4 [4 (2 FLUOROETHYL)PHENYL]BUTYL]THYMIDINE F 18; N 3 [5 [4 (2 FLUOROETHYL)PHENYL]PENTYL]THYMIDINE F 18; RADIOPHARMACEUTICAL AGENT; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG PURITY; DRUG SYNTHESIS; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 77953803573     PISSN: 18744710     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874471010902010002     Document Type: Article

References (41)

1. 76Br]bromo-2′-fluoro-2′-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model. Eur. J. Nucl. Med., 2002, 29, 19-27.
2. Lea, M.A.; Moris, H.P.; Weber, G. Comparative biochemistry of hepatomas: VI. Thymidine incorporation into DNA as a measure of hepatoma growth rate. Cancer Res., 1966, 26, 465-69.
3. Al-Madhoun, A.S.; Tjarks, W.; Eriksson, S. The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev. Med. Chem., 2004, 4, 341-50.
4. Sherly, J.L.; Kelly, T.J. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem., 1988, 263, 8350-58.
5. 11C]thymidine. Proc. Natl. Acad. Sci., 1972, 69, 988-92.
6. Shields, A.F.; Lim, K.; Grierson, J.L.; Krohn, K.A. Utilization of Labeled thymidine in DNA synthesis: studies for PET. J. Nucl. Med., 1990, 31, 337-42.
7. Vander Borght, T.; Pauwels, S.; Lambotte, L.; Labar, D.; De Maeght, S.; Stroobandt, G.; Laterre, C. Brain tumor imaging with PET and 2-[carbon-11]thymidine. J. Nucl. Med., 1994, 35, 974-82.
8. Conti, P.S.; Hilton, J.; Wong, D.F.; Alauddin, M.M.; Dannals, R.F.; Ravert, H.T.; Wilson, A.A.; Anderson, J.H. High performance liquid chromatography of methyl-C-11-thymidine and its major metabolites for clinical PET studies. Nucl. Med. Biol., 1994, 21, 1045-51.
9. Watanabe, K.A.; Su, T.L.; Riechman, U.; Greenberg, N.; Lopez, C.; Fox, J.J. Nucleosides 129. Synthesis of antiviral nucleosides: 5-Alkenyl 1-(2-deoxy-2-fluoro--D-arabinofuranosyl)-uracils. J. Med. Chem., 1984, 27, 91-94.
10. Tann, C.H.; Brodfuehrer, P.R.; Brundidge, S.P.; Sapino, C.; Howell, H.G. Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro--D-arabinofuranosyl)-5-iodouracil (FIAU) and 1-(2-deoxy-2-fluoro-D-arabinofuranosyl)thymine (FMAU). J. Org. Chem., 1985, 50, 3644-47.
11. 11C]-FMAU): A potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl. Med. Biol., 1995,22, 783-89.
12. 18F] FMAU). J. Labell. Comp. Radiopharm., 2002, 45, 583-90.
13. Tjuvajev, J.G.; Homer, A.; Macapinlac, H.A.; Daghighian, F.; Scott, A.M.; Ginos, J.Z.; Finn, R.D.; Kothari, P.; Desai, R.; Zhang, J.; Beattie, B.; Graham, M.; Larson, S.M.; Blasberg, R.G. Imaging of brain tumor proliferative activity with Iodine-131-iododeoxyuridine. J. Nucl. Med., 1994, 35, 1407-17.
14. 14C]uracils. J. Med. Chem., 1987, 30, 670-75.
15. Tjuvajev, J.G.; Doubrovin, M.; Akhurst, T.; Cai, S.; Balatoni, J.; Alauddin, M.M.; Finn, R.; Bornmann, W.; Thaler, H.; Conti, P.S.; Blasberg, R.G. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med., 2002, 43, 1072-83.
16. Alauddin, M.M.; Shahinian, A.; Gordon, E.M.; Conti, P.S. Evaluation of 2′-deoxy-2′-fluoro-5-methyl-1--D-arabinofuranosyluracil (FMAU) as a potential gene imaging agent for HSV-tk expression in vivo. Mol. Imaging., 2002, 1, 74-81.
17. 18F]FCAU), and their biological evaluation as markers for gene expression. Nucl. Med. Biol., 2004, 31, 399-405.
18. Alauddin, M.M.; Shahinian, A.; Gordon, E.M.; Conti, P.S. Direct comparison of radiolabeled probes FMAU, FHBG and FHPG as PET imaging agents for HSV1-tk gene expression in human breast cancer model. Mol. Imaging., 2004, 3, 76-84.
19. 18F]-FFAU as a potential PET imaging agent for gene expression. J. Nucl. Med., 2004, 45, 2063-69.
20. 18F]-FMXU) for PET. J. Labell. Comp. Radiopharm., 2005, 48, 941-50.
21. Grierson, J.R.; Shields, A.F. Radiosynthesis of 3 -deoxy-3 [18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo. Nucl. Med. Biol., 2000, 27, 143-56.
22. 11CFMAU). Comparison studies with FDG. RSNA, 2002, Dec. 5-9, Chicago, IL.
23. Conti, P.S.; Bading, J.R.; Mouton, P.; Links, J.M.; Alauddin, M.M.; Fissekis, J.D.; Ravert, H.T.; Hilton, J.; Wong, D.F.; Anderson, J.H. In vivo measurement of cell proliferation in canine brain tumor using C-11 labeled FMAU and PET. Nucl. Med. Biol., 2008, 35,131-41.
24. 18F]FMAU and positron emission tomography in patients with cancer. Eur. J. Nucl. Med. Mol. Imaging, 2005, 32, 15-22.
25. Tehrani, O.S.; Muzik, O.; Heilbrun, L.K.; Douglas, K.A.; Lawhorn-Crews, J.M.; Sun, H.; Mangner, T.J.; Shields, A.F. Tumor imaging using 1-(2′-deoxy-2′-fluoro-1--D-arabinofuranosyl)thymidine and PET. J. Nucl. Med., 2007, 48, 1436-41.
26. 18FFDG. J. Nucl. Med., 2003, 44, 1426-31.
27. 18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice. J. Nucl. Med., 2004, 45, 1754-58.
28. 18F]3 -deoxy-3 -fluorothymidine metabolism and retention. Eur. J. Nucl. Med. Mol. Imag., 2005, 32, 1269-75.
29. 14C]FMAU in rat prostate tumor cells. Nucl. Med. Biol., 2000, 27, 361-68.
30. Lunato, A.J.; Wang, J.; Woollard, J.E.; Anisuzzaman, A.K.M.; Ji, W.; Rong, F-G.; Ikeda, S.; Soloway, A.H.; Eriksson, S.; Tjarks, W. Synthesis of 5-(carboranylalkylmercapto)-2 -deoxyuridines and 3(carboranylalkyl)-thymidines and their evaluation as substrates for human thymidine kinase. J. Med. Chem., 1999, 42, 3373-89.
31. Al-Madhoun, A.S.; Johnsamuel, J.; Yan, J.; Ji, W.; Wang, J.; Zhou, J.; Lunato, A.; Woollerd, J.E.; Hawk, A.E.; Blue, T.E.; Tjarks, W.; Eriksson, S. Synthesis of a small library of 3-(carboranylalkyl)thymidines and their biological evaluation as substrates for human thymididne kinses 1 and 2. J. Med. Chem., 2002, 45, 4018-28.
32. Byun, Y.; Yan, J.; Al-Madhoun, A.S.; Johnsamuel, J.; Yang, W.; Barth, R.F.; Eriksson, S.; Tjarks, W. The synthesis and biological evaluation of thymidine analogues substituted with nido and carborane at the N-3 position. Appl. Radiat. Isot., 2004, 61, 1125-30.
33. Al-Madhoun, A.S.; Johnsamuel, J.; Barth, R.F.; Tjarks, W.; Eriksson, S. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res., 2004, 64, 6280-86.
34. Byun, Y.; Yan, J.; Al-Madhoun, A.S.; Johnsamuel, J.; Yang, W.; Barth, R.F.; Eriksson, S.; Tjarks, W. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy. J. Med. Chem., 2005, 48, 1188-98.
35. Bandyopadhyaya, A.K.; Johnsamuel, J.; Al-Madhoun, A.S.; Erikson, S.; Tjarks, W. Comparative molecular field analysis and comparative molecular similarity indices analysis of human thymidine kinase 1 substrates. Bioorg. Med. Chem., 2005, 13, 1681-89.
36. 18F]-FPT) for PET. J. Labelled. Comp. Radiopharm., 2006, 49, 1079-88.
37. Toyohara, J.; Hayashi, A.; Gogami, A.; Fujibayashi, Y. Alkylfluorinated thymidine derivatives for imaging cell proliferation I. The in vitro evaluation of some alkyl-fluorinated thymidine derivatives. Nucl. Med. Biol., 2006, 33, 751-64.
38. 18F]fluoroethyl)-thymidine. Nucl. Med. Biol., 2006, 33, 765-72.
39. 18F]-FMPPT) for PET. J. Labelled. Comp. Radiopharm., 2007, 50, 1185-95.
40. 18F]fluoropropyl thymidine. Nucl Med Biol., 2008, 35, 697-05.
41. Alauddin, M.M.; Conti, P.S. Selective alkylation of pyrimidyl dianions: Synthesis, characterization and comparative reactivity of 3′, 5′-o-bis-tetrahydropyranyl, trimethylsilyl and t-butyldimethylsilyl derivatives of 5-bromo-2′-deoxyuridine. Tetrahedron, 1994, 50, 1699-706.